Stay updated with breaking news from Upstream Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Construction of Samsung Biologics’ new facility is on track, with the CDMO saying pre-sales activities are ongoing for Plant 4, as it is known, despite the challenging business environment amid the COVID-19 pandemic.
Biotecnica has launched a new line of low endotoxin peptones that do not require ultrafiltration.
Rentschler Biopharma and XL-protein have teamed up on the manufacture of what they say is a long-acting, hyperactive recombinant human deoxyribonuclease I (DNase I) that may open better treatment options for patients suffering from inflammation, chronic or autoimmune diseases.
Merck has launched new technology and is set to expand manufacturing capacity to advance antibody-drug conjugates (ADC) therapies.
From industrializing mRNA manufacture to the implications of a potential IP waiver on COVID-19 vaccine production, hear from the experts in our free webinar this week.